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Abstract
Background—Our objective was to evaluate associations between twinning and maternal 
demographic factors and periconceptional exposures among infants with and without orofacial 
clefts.
Methods—We used data from the National Birth Defects Prevention Study; 228 twins and 8,242 
singletons without birth defects (controls), and 117 twins and 2,859 singletons with orofacial 
clefts, born 1997–2007, were included in the analyses. Because of the occurrence of twinning due 
to the use of assisted reproductive technologies, logistic regression models were computed to 
estimate odds ratios (OR) and 95% confidence intervals (CIs) for each exposure, stratified by 
fertility treatment use. To evaluate factors by zygosity, we used sex-pairing data and a simulation 
approach to estimate the zygosity of like-sex twin pairs for unassisted conceptions.
Results—Among control mothers who did not use fertility treatments, predictors of twinning 
included non-Hispanic black maternal race (adjusted OR: 1.6, 95% CI: 1.0–2.4), and tobacco 
smoking (1.6, 1.1–2.4). Among control mothers who used fertility treatments, older maternal age, 
higher income, and state of residence were associated with twinning. Associations were generally 
stronger among mothers of dizygotic (estimated) twins than monozygotic (estimated) twins. 
Results for mothers of infants with isolated orofacial clefts were similar to those of controls.
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Conclusion—We observed an increased twinning frequency with increasing maternal age, but 
factors such as maternal race/ethnicity and socioeconomic status may also contribute. Among 
women receiving fertility treatments, factors associated with twinning suggested a relation with 
treatment specifics (e.g., treatment type and number of embryos implanted) and availability of 
insurance coverage.
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INTRODUCTION
In 2011, one in every 30 babies born in the United States was a twin (Martin et al., 2013). 
Twinning is associated with a number of pregnancy complications and adverse maternal and 
fetal outcomes (Helmerhorst et al., 2004; Boulet et al., 2008; Morcel et al., 2010; Yang et 
al., 2011). Mothers of multiples have twice the risk of pregnancy-related mortality and an 
increased risk of preterm labor and cesarean delivery (Conde-Agudelo et al., 2000). 
Compared to singletons, twins are at a higher risk of low birth weight, birth defects, 
prematurity, and infant mortality (Martin and Park, 1999; Li et al., 2003a; Tang et al., 2006; 
Chauhan et al., 2010; Zhang et al., 2011). The increased risk for adverse outcomes is 
particularly concerning given the increasing rate of twin births in the United States from 
1980 (18.9 per 1000) to 2011 (33.2 per 1000) (Martin et al., 2013).
Recent studies have estimated that approximately 19% of US twin births are attributable to 
assisted reproductive technology (ART) and an additional 19% of twin births are attributable 
to non-ART ovulation stimulation treatments (Sunderam et al., 2012; Kulkarni et al., 2013). 
Other factors that are associated with twinning include a family history of twinning, older 
maternal age, multiparity, obesity, and African-American race (Khoury and Erickson, 1983; 
Allen and Parisi, 1990; Martin and Park, 1999; Hoekstra et al., 2010). The relationships 
between twinning and oral contraceptives, folic acid-containing multivitamins, and maternal 
smoking have been examined, with conflicting results (Rothman, 1977; Olsen et al., 1988; 
Czeizel et al., 1994; Li et al., 2003b; Muggli and Halliday, 2007; Hoekstra et al., 2010).
Although twinning has been studied extensively, much of the work involving risk factors for 
twinning was conducted before fertility treatments were in widespread use. Given the steady 
increase in use of assisted reproduction, understanding the factors associated with multiple 
births in this population is important (Centers for Disease Control and Prevention et al., 
2011). In addition, few studies have evaluated factors associated with twinning among 
mothers whose offspring have birth defects (Tang et al., 2006; Zhang et al., 2011). Our 
objectives were to use data from the National Birth Defects Prevention Study (NBDPS) to 
evaluate maternal demographic factors and periconceptional exposures associated with 
twinning, stratified by use of fertility treatments. We assessed these associations among 
mothers of unaffected controls. We also included mothers of infants or fetuses with a birth 
defect (cases) so that we might compare these findings with those of control mothers. 
Because twinning is associated with an increased risk of birth defects, we were interested in 
factors associated with twinning that were unique to the case group, as we hypothesized that 
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these factors may be related to both the birth defect and twinning. In order to minimize 
heterogeneity, we selected one phenotype - isolated cleft lip with/without cleft palate or cleft 
palate only (cases) - as these are some of the more common birth defects that have 
previously been associated with twinning (Mastroiacovo et al., 1999; Tang et al., 2006; 
Zhang et al., 2011).
MATERIALS AND METHODS
Study Population
The NBDPS was a multi-center case-control study of major birth defects in the United 
States that completed data collection in 2013. NBDPS is a collaborative effort of the Centers 
for Birth Defects Research and Prevention in Arkansas, California, Georgia, Iowa, 
Massachusetts, North Carolina, New Jersey, New York, Texas, and Utah. Institutional 
Review Boards at each site approved the study. Methods for recruitment of participants and 
data collection have been described in detail (Yoon et al., 2001; Rasmussen et al., 2003). 
Briefly, eligible cases included infants or fetuses with major birth defects identified through 
population-based surveillance systems at each site. Controls, live-born infants without major 
birth defects, were randomly selected using birth certificates or birth hospital records from 
the same ascertainment area and time period as the cases. Per study protocol, only one infant 
per family was eligible for NBDPS participation; when both twins met inclusion criteria, the 
first-born twin was included.
Mothers of cases and controls participated in a computer-assisted telephone interview, 
which included questions regarding pregnancy history, demographics, and exposures that 
occurred from three months before conception through the end of the pregnancy. Mothers 
were interviewed in English or Spanish between six weeks and 24 months after their 
expected date of delivery (EDD).
Our study population included mothers of control twins (n=228) and singletons (n=8,242), 
and mothers of case twins (n=117) and singletons (n=2,859) with EDD between October 1, 
1997 and December 31, 2007. Mothers of higher order multiples were excluded. Clinical 
information was reviewed by a clinical geneticist (SAR) to identify cases with isolated clefts 
(no additional unrelated major defect and no known genetic conditions) (Rasmussen et al., 
2003).
Outcome
The outcome of interest for this analysis was twin pregnancy, as compared to singleton 
pregnancy. During the interview, mothers were asked, “In this pregnancy, how many babies 
were you carrying?” If necessary, a second question was asked, “Did you have a single 
baby, twins, or more babies?” Secondary sources of plurality information were birth 
certificates and/or maternal medical records. Mothers of 17 controls and five cases did not 
answer the plurality question, but clinical records indicated they were singletons. 
Approximately 18% of maternally reported twin control infants (n=41/228) and twin cases 
(n=21/117) were reported as singletons on the birth certificate. This could be due to clerical 
errors or to death of a co-twin in utero. Therefore, we elected to defer to the maternal 
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interview response. All infants reported as singletons during the interview were also 
identified as singletons on birth certificates. One control mother was excluded due to 
missing information on plurality in both information sources.
Exposure
We examined the association between twinning and maternal characteristics that were 
previously reported to be associated with twinning including fertility treatments, race/
ethnicity, age, height, pre-pregnancy weight, pre-pregnancy body mass index (BMI), parity, 
education, income, tobacco smoking, oral contraceptive use, and use of a folic acid-
containing multivitamin. All exposures were self-reported by mothers. Fertility treatment 
was defined as any use of fertility-enhancing medications (e.g., clomiphene citrate) and/or 
ART (in vitro fertilization [IVF], gamete intrafallopian transfer, zygote intrafallopian 
transfer, tubal embryo transfer, and intracytoplasmic sperm injection) and clomiphene citrate 
use only. Women were excluded from the analyses stratified by use of fertility treatments if 
they reported use of only non-medical fertility treatments (e.g., consumption of teas, use of 
acupuncture). As our focus was on maternal characteristics associated with twinning, 
mothers reporting only paternal treatments (e.g., vasectomy reversal) were also excluded.
Maternal cigarette smoking, oral contraceptives, and folic acid-containing multivitamins 
were assessed for the exposure window from one month before through the first month of 
pregnancy. In order to be consistent with previous analyses of twinning and body 
composition, maternal height and maternal pre-pregnancy weight were examined separately 
and were categorized as quartiles among mothers of singleton controls (height: < 159, 159–
163, 164–168, and > 168 cm; pre-pregnancy weight: < 57, 57–64, 65–74, > 74 kg) (Basso et 
al., 2004; Reddy et al., 2005; Hoekstra et al., 2010). Pre-pregnancy BMI was categorized 
according to NIH guidelines: underweight (< 18.5), normal weight (18.5–24.9), overweight 
(25–29.9), and obese (≥ 30) (National Heart Lung and Blood Institute, 2000). Study site and 
year of EDD were also included as covariates.
Statistical Analyses
Logistic regression analyses were used to estimate crude odds ratios (ORs) and 
corresponding 95% confidence intervals (CI). Models were also stratified by fertility 
treatment, comparing maternal fertility use to unassisted conception. In the analyses of 
mothers who reported unassisted conceptions, we calculated adjusted estimates using 
multivariable logistic regression, controlling for covariates selected a priori using causal 
diagrams, also known as directed acyclic graphs (Greenland et al., 1999).
Previous studies have shown that predictors of twinning may vary depending on zygosity 
(Basso et al., 2004; Hankins and Saade, 2005; Hoekstra et al., 2010). The NBDPS does not 
routinely collect information on zygosity or sex of the co-twin. Therefore, the sex of many 
of the co-twins was obtained through linkage with birth certificates utilizing maternal name, 
infant name, and infant date of birth to merge records. The co-twin’s sex for 176 of 228 
control twin pairs (77.2%) was identified: 60 male-male pairs, 52 female-female pairs, and 
64 male-female pairs. These data were not available for Utah participants; therefore the twin 
(n=17) and singleton (n=591) controls from this Center were excluded from the zygosity 
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sub-analysis. Due to small sample size, the zygosity sub-analysis was not conducted for case 
twins among which there were 49 (60.5%) same sex pairs, and 32 (39.5%) unlike sex pairs.
Unlike-sex twin pairs are dizygotic, but the zygosity of like-sex pairs cannot be identified 
without further information. To estimate the zygosity of like-sex pairs, we utilized a 
simulation modeling approach. The steps in this approach were: calculate the proportion of 
male twins in our sample, estimate the proportion of DZ twins among control twins, 
estimate the proportion of MZ twins among the like-sex twins in our sample, simulate 1,000 
datasets with zygosity randomly assigned to each like-sex twin pair, estimate ORs for each 
factor of interest in each dataset using logistic regression, and, finally, obtain summary ORs 
and 95% uncertainty intervals for each factor of interest (see Appendix). The parameters for 
modeling zygosity were obtained from equations described in 2009 by Hardin et al. We also 
estimated ORs and 95% CIs for the association between the variables of interest and 
twinning for the like-sex and unlike-sex pairs as a more traditional method of accounting for 
zygosity. SAS version 9.3 (Cary, NC) was used to conduct all analyses.
RESULTS
Approximately 2.7% (n=228/8470) of control mothers reported a twin gestation compared to 
3.9% (n=117/2976) of case mothers (i.e. fetus/infant with orofacial cleft). The interview 
participation rate was 68.4% for mothers of cases and 65.7% for mothers of controls. 
Approximately 31.1% of mothers of control twins and 29.9% of mothers of case twins 
reported use of fertility treatments (Table 1). Fertility treatment use was significantly 
associated with twinning for control mothers (OR: 14.5, 95% CI: 10.7–19.8) and case 
mothers (OR: 9.5, 95% CI: 6.2–14.8). ART use and clomiphene citrate use were 
significantly associated with twinning among control mothers (OR: 51.0, 95% CI:31.8–81.7; 
OR:6.1, 95% CI:3.5–10.7, respectively) and case mothers (OR:23.6, 95% CI:12.8–43.6; OR: 
5.3, 95% CI:2.5–11.1, respectively).
Results were generally similar for case and control mothers (Table 1). Among control 
mothers, twinning increased with increasing maternal age: 58.8% of mothers of twins were 
age 30 years or greater, compared to 38.4% of mothers of singletons. Among control 
mothers, other factors significantly associated with an increased prevalence of twinning in 
bivariate analyses were higher education (> than a high school graduate), higher income (> 
$50,000 per year), and use of a folic acid-containing multivitamin. Hispanic control mothers 
were also less likely to have twins compared to non-Hispanic white mothers. Among 
mothers of cases with clefts, significant predictors of twinning were taller maternal height, 
higher maternal income, and use of a folic-acid containing multivitamin. A sensitivity 
analysis restricted to mothers who reported plurality during the interview that matched birth 
certificates (control twins: n=187; case twins: n=96) resulted in very similar findings (data 
not shown).
Several factors were found to be significantly associated with twinning among control 
mothers who reported unassisted conception (Table 2). For these women, the association 
between non-Hispanic black race and twinning was of borderline significance after adjusting 
for study site (adjusted odds ratio [ aOR]:1.6, 95% CI: 1.0–2.4). Increasing parity was 
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modestly associated with twinning, with ORs of borderline statistical significance after 
adjusting for maternal age, race/ethnicity, education level, annual household income, and 
study site (1 previous live birth: 1.4, 0.9–2.1; 2+ previous live births: 1.6, 1.0–2.5). Maternal 
tobacco smoking was significantly associated with twinning after adjusting for maternal age, 
race/ethnicity, education level, annual household income, parity, study site, and year of EDD 
(1.6, 1.1–2.4).
Among the control mothers who reported any use of fertility treatments, twinning was more 
frequent among mothers aged 30–34 years compared to mothers aged 25–29 years (Table 2). 
The proportion of non-Hispanic white mothers was slightly higher among mothers of twins 
(91.6%) than among mothers of singletons (83.9%). The odds of twinning were 4.3 times 
higher for mothers with an annual household income ≥ $50,000 compared to those with an 
income between $10,000 and $50,000 (95% CI: 1.9–9.9). Twinning was less common 
among mothers 159–163 cm tall than among mothers <159 cm tall.
Among case mothers who did not report use of fertility treatments, non-Hispanic black 
women were more than twice as likely as non-Hispanic white women to have a twin 
pregnancy (aOR 2.3, 95% CI: 1.1–4.6) (Table 3). Compared to women with no previous live 
births, women with at least two previous live births had a modestly increased risk of a twin 
pregnancy that was of borderline statistical significance (1.7; 95% CI: 0.9–3.1). Mothers 
from New York were also significantly more likely to have a twin pregnancy than their 
counterparts from Georgia, although this association was of borderline significance after 
adjusting for year of EDD. Overall, the associations for case mothers were similar to the 
findings from the controls analysis, with the notable exception that there was no association 
observed for smoking and twinning among case mothers reporting unassisted conception. 
We did not observe any significant associations with twinning among case mothers who 
reported use of fertility treatments, although the small sample size limited our ability to 
detect associations in this group.
Associations with twinning for the unlike-sex control twins and estimated dizygotic twins 
were similar to the associations observed for all control twins (Table 4). Fewer associations 
were observed for the like-sex and estimated monozygotic control twins.
DISCUSSION
Twin pregnancies occurred in approximately 2.7% of control mothers in the NBDPS, similar 
to the U.S. twin birth rate of 3% during the same time period (Martin et al., 2013). As 
expected, fertility treatment use was a significant predictor of twinning, both for mothers of 
controls and of cases with isolated orofacial clefts. Our results support previous reports of an 
association between fertility treatments and MZ twinning (Aston et al., 2008). Given the 
magnitude of the associations for ART and clomiphene citrate, it may appear that our results 
indicate a greater contribution of ART births to the overall twinning rate compared to non-
ART treatments, in contrast to previous studies (Kulkarni et al., 2013). However, when 
comparing the proportion of twins attributable to IVF with non-IVF treatments, without 
adjusting for maternal age, our results (16.7% of twins and 14.5%, respectively) were 
similar to those of Kulkarni et al (2013). We did not find any evidence to suggest a 
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difference in the factors associated with twinning for unaffected controls and cases with 
orofacial clefts.
Historically, maternal age has been cited as a strong predictor of twinning (Bulmer, 1970; 
Bortolus et al., 1999). A recent report found the natural dizygotic twinning rate was 
relatively stable between 1969–2009 after controlling for maternal age (Derom et al., 2011). 
We found an association between maternal age and twinning for mothers reporting assisted 
conception but not among mothers reporting unassisted conception. One explanation for the 
discrepancy may be that we could not account for zygosity in our primary analyses, and 
previous studies have suggested that the association with maternal age may be limited to 
mothers of DZ twins (Bulmer, 1970). In our zygosity sub-analysis we observed a trend of 
increased frequency of twinning with increasing maternal age for MZ and DZ twins, 
although the association was not statistically significant for MZ twin mothers. Our finding 
that the association between maternal age and twinning was attenuated after controlling for 
fertility treatment use, maternal race/ethnicity, education level, annual household income, 
study site and year of EDD may suggest that this association is more complex than 
previously described.
Other factors associated with both fertility treatments and twinning such as education, pre-
pregnancy weight, and use of a folic acid-containing multivitamin were associated with 
twinning when not controlling for fertility treatment use but were no longer associated after 
the models were stratified by fertility treatment use. The possibility of an association 
between folic acid and twinning has been particularly controversial (Werler et al., 1997; Li 
et al., 2003b). Our study found little difference in folic acid intake during the pregnancies of 
twin and singleton mothers reporting unassisted conception. In the ART stratum, almost all 
mothers reported taking folic acid. Although more twin mothers reported taking folic acid, 
this association was not statistically significant.
Among mothers who reported unassisted conception, a moderate increase in the frequency 
of twinning was observed for mothers who were non-Hispanic black, who reported two or 
more previous live births, and who smoked cigarettes between one month prior to 
conception through the first month of pregnancy, which is consistent with previous findings 
(Bulmer, 1970; Nylander, 1981; Hoekstra et al., 2010).
The associations we observed for mothers reporting fertility treatments likely reflect the cost 
of fertility treatments or choices regarding treatment options, such as implanting multiple 
embryos, rather than causal factors. The association between income and twinning may be 
due to treatments such as IVF being cost-prohibitive to lower income families and many 
insurers do not provide coverage for these treatments (American Society for Reproductive 
Medicine, 2014). Cost has been previously cited as a factor related to the socioeconomic and 
ethnic disparities among women utilizing fertility treatments (Smith et al., 2011). Similarly, 
the large proportion of twin births in MA are likely due to state mandates that insurers 
provide coverage for fertility treatments, including IVF (Martin et al., 2011). For women 
receiving IVF, choices regarding the number of embryos implanted are an important 
consideration, although not one that we were able to analyze.
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Our study has several limitations. First, our study was limited by the relatively small sample 
size after stratifying by fertility treatment use and estimated zygosity. We were unable to 
conduct multivariable analyses for mothers reporting fertility treatment use. We relied on 
self-reported data from a retrospective maternal interview, so we cannot rule out exposure 
misclassification due to inaccurate recall. The average age at interview was nine months for 
controls (singletons: 9.3 months; twins: 10.1 months) and 11 months for cases (singletons: 
10.7 months; twins: 11.3 months). The study participation rate was slightly higher among 
mothers of twins than mothers of singletons for both controls (singletons: 65.4%; twins: 
68.7%) and cases (singletons: 68.2%; twins: 71.6%). We were not able to verify the 
accuracy of the responses for reported periconceptional exposures or reported use of fertility 
treatments. For mothers who reported fertility treatment use, we were unable to determine 
the number of embryos implanted, a strong predictor of twinning (Templeton and Morris, 
1998). Another limitation is that a comparison of the plurality reported by the mothers in the 
interview with information recorded on the infant’s birth certificate or mother’s hospital 
record revealed some discrepancies, with mothers reporting higher rates of twin gestation. 
Although previous studies have found a high degree of concordance between plurality from 
maternal report and on birth certificates, some variability exists and may be due to clerical 
errors or early fetal demise of a co-twin (Querec, 1980; Schoendorf et al., 1993). 
Ascertainment of early fetal demise has likely increased since these previous studies due to 
increased use of early ultrasonography. A sensitivity analysis restricted to control infants 
without plurality discrepancies produced results similar to those from the primary analysis.
We were also unable to directly determine zygosity. This limitation is important because 
many factors have only been associated with DZ twinning (Bulmer, 1970; Hoekstra et al., 
2010). Zygosity is particularly difficult to obtain as the gold-standard for determining 
zygosity is genetic analysis (Chen et al., 1999). However, our simulation modeling approach 
may be useful as it allowed us to estimate risk factor associations for MZ and DZ twins with 
accompanying uncertainty intervals. Although we attempted to assess factors associated 
with zygosity of twins, there are other features of twinning, such as chorionicity, that we 
were not able to assess using these data.
Strengths of this study include use of a demographically diverse, population-based sample 
from ten different states across the United States. We were able to control for a variety of 
factors associated with twinning. This analysis assesses potential risk factors for twinning 
among a modern sample of mothers that reported fertility treatment use in addition to 
mothers that reported unassisted conception of twins.
Fertility treatment use was a strong predictor of twinning, as expected, but the factors 
associated with twinning among women receiving fertility treatments are likely due, in part, 
to the type of treatment, number of embryos implanted, and the availability of insurance 
coverage. We observed an increase in twinning with increasing maternal age, but factors 
such as maternal race/ethnicity and socioeconomic status may contribute and should be 
examined further. Given the increased risk of adverse outcomes associated with a twin 
pregnancy, understanding the factors associated with twinning, be it unassisted or assisted, is 
of public health importance.
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